Posting of Circular and Notice of GM
Futura Medical plc has announced the posting of a Circular and Notice of General Meeting to shareholders following its £2.75 million fundraise. The General Meeting is scheduled for December 2, 2025, at the company's registered office, where voting results on all resolutions will be announced via RNS and published on the company's website.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Futura Medical plc (AIM: FUM), the consumer healthcare Group behind Eroxon®, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, announces that further to the announcement on 13 November 2025 relating to its fundraise of £2.75 million, it has despatched the Circular and Notice of General Meeting to Shareholders.
The Circular and Notice of General Meeting is available on the Company's website: Corporate documentation - Futura Medical
The Directors confirm they are to hold a General Meeting of the Company at the Company's registered office at Surrey Technology Centre, 40 Occam Road, Guildford, Surrey, GU2 7YG at 10 a.m. on 2 December 2025.
The results of voting on all resolutions at the General Meeting will be announced via RNS, and the full results of the voting will be published on the Company's website after the conclusion of the General Meeting.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.